Related Experiment Videos
[Final body height affecting factors in Turner syndrome]
1Borsod-Abaúj-Zemplén Megyei Kórház-Rendelóintézet, Gyermekegészségügyi Központ, III, Csecsemö-és Gyermekosztály, Miskolc.
Orvosi Hetilap
|August 3, 1997
Summary
Optimizing growth hormone (GH) treatment for girls with Turner syndrome requires identifying key growth factors. Understanding patient-specific needs and factors like age and bone age improves predicted final height outcomes.
Area of Science:
- Pediatric Endocrinology
- Genetics and Genetic Diseases
Context:
- Turner syndrome is a genetic condition affecting girls, often leading to short stature.
- Growth hormone therapy is a common treatment to improve height outcomes in Turner syndrome.
- Personalizing treatment based on individual patient factors is crucial for maximizing efficacy.
Purpose:
- To investigate the correlation between initial treatment parameters and projected final height in girls with Turner syndrome receiving growth hormone therapy.
- To identify factors that can predict treatment response and optimize growth hormone dosage and initiation timing.
Summary:
- This study examined the relationship between baseline factors (age, bone age, target height, height SDS) and projected final height in girls with Turner syndrome undergoing growth hormone treatment.
- Linear regression analysis was used to determine these correlations.
- Findings suggest that early initiation and appropriate dosage of growth hormone are vital, as supported by current literature.
Impact:
- Provides insights into optimizing growth hormone therapy for Turner syndrome by highlighting the importance of specific predictive factors.
- Aims to improve final height outcomes for girls with Turner syndrome through more individualized treatment strategies.
- Contributes to evidence-based guidelines for managing growth deficiencies in genetic conditions.